No Data
Down -38% in 4 Weeks, Here's Why You Should You Buy the Dip in PROKIDNEY CP (PROK)
ProKidney Hold Rating: Balancing Developmental Progress and Financial Stability Amid Uncertainty
ProKidney | 10-K: FY2024 Annual Report
ProKidney Corp. Reports 2024 Financial Results and Milestones in Rilparencel Development for Chronic Kidney Disease
ProKidney Sees Cash Runway Into Mid-2027
Express News | ProKidney FY 2024 GAAP EPS $(0.62) Misses $(0.57) Estimate, Ended The Fourth Quarter With $358M In Cash And Cash Equivalents And Marketable Securities, Supporting Operations Into Mid-2027
